Pre-targeting MDA-MB-468 breast cancer cells with anti-PEG:anti-EGFR BsAbs significantly increased EGFP expression compared to pre-mixing (12- vs. 3-fold improvement over mRNA-LNPs alone; Figures 2A, 2B, and S1D). The gene discussed is EGFR; the disease is breast carcinoma.